Effects of EGFR Gene Polymorphisms on Efficacy and Prognosis 
in Advanced Non-small Cell Lung Cancer Treated with EGFR-TKIs

Effects of EGFR Gene Polymorphisms on Efficacy and Prognosis 
in Advanced Non-small Cell Lung Cancer Treated with EGFR-TKIs

An increasing number of patients with advanced non-small cell lung cancer (NSCLC) have been treated with epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs). However, significant differences in response to EGFR-TKIs have been shown among advanced NSCLC patients. Recently, selecti...

Full description

Bibliographic Details
Main Authors: Liangshan DA, Lin XU
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2013-03-01
Series:Chinese Journal of Lung Cancer
Subjects:
EGFR-TKIs
Lung neoplasms
Polymorphisms
Efficacy
Prognosis
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2013.03.09

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2013.03.09

Similar Items